Cycloserine labels and packages: Difference between revisions
No edit summary |
No edit summary |
||
| Line 4: | Line 4: | ||
== | ==Package Label Principal Display Panel== | ||
SEROMYCIN cycloSERINE Capsules, USP 250mg THE CHAO CENTER NDC 13845-1200-3 40 capsules Rx only | SEROMYCIN cycloSERINE Capsules, USP 250mg THE CHAO CENTER NDC 13845-1200-3 40 capsules Rx only | ||
Revision as of 14:44, 27 December 2013
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]
Package Label Principal Display Panel
SEROMYCIN cycloSERINE Capsules, USP 250mg THE CHAO CENTER NDC 13845-1200-3 40 capsules Rx only
Usual Initial Adult Dose: One capsule (250 mg) twice a day at 12 hour intervals. See accompanying literature. Dispense in a tight container.
WARNING: Potent drug. May cause serious reactions in some individuals. Use in patients under close medical supervision. Read accompanying literature before using.
13845-1200-3
LM000250.00
Keep tightly closed. Store at controlled room temperature, 20 degrees to 25 degrees C (68 degrees to 77 degrees F). [see USP]
Maunfacture The Chao center for Industrial Pharmacy and Contract Manufacturing, West Lafayette, IN 47906, USA
Expiration Date Batch No.[1]
 |
References
- ↑ "SEROMYCIN (CYCLOSERINE) CAPSULE [PURDUE GMP CENTER LLC DBA THE CHAO CENTER]". Text " accessdate " ignored (help)
Adapted from the FDA Package Insert.